Minocycline-Induced Scleral and Dermal Hyperpigmentation

被引:8
作者
Haskes, Cheryl [1 ]
Shea, Michael [2 ]
Imondi, David [1 ]
机构
[1] VA Connecticut Healthcare Syst, Newington, CT USA
[2] Blondin Shea Eye Care, Torrington, CT USA
关键词
minocycline; blue sclera; medication side effects; hyperpigmentation; deposition; HYPER-PIGMENTATION; SKIN PIGMENTATION; ADDISONS-DISEASE; THERAPY; SAFETY;
D O I
10.1097/OPX.0000000000001024
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose To present a case of minocycline-induced blue scleral pigmentation and discuss the pathophysiology and differential diagnoses. The uses, mechanisms, and other adverse effects of minocycline will also be highlighted. Case Report An elderly Caucasian male patient presented for routine ocular examination complaining of blue discoloration to the whites of his eyes. He was found to have bilateral blue scleral pigmentation and blue discoloration to various other dermal areas of his body. The blue pigmentation was also visible in the posterior segment within a scleral crescent around his right optic nerve. This pigmentation was determined to be caused by long-term use of oral minocycline. Conclusions Long-term minocycline use may induce scleral, dermal, and organ hyperpigmentation, typically blue or black in coloration. The pigmentation may reverse with discontinuation of the medication, but can also be permanent. The exact mechanism of pigment deposition remains uncertain, but several theories have been proposed. While the cosmetic appearance may be dramatic, this side effect is not known to cause any systemic or ocular morbidity.
引用
收藏
页码:436 / 442
页数:7
相关论文
共 48 条
  • [1] BLACK THYROID - CLINICAL MANIFESTATIONS, ULTRASTRUCTURAL FINDINGS, AND POSSIBLE MECHANISMS
    ALEXANDER, CB
    HERRERA, GA
    JAFFE, K
    YU, H
    [J]. HUMAN PATHOLOGY, 1985, 16 (01) : 72 - 78
  • [2] PATIENTS PRESENTING WITH ADDISONS-DISEASE NEED NOT BE PIGMENTED
    BARNETT, AH
    ESPINER, EA
    DONALD, RA
    [J]. POSTGRADUATE MEDICAL JOURNAL, 1982, 58 (685) : 690 - 692
  • [3] Pigmented conjuctival lesions as initial manifestation of ochronosis
    Barrios, PC
    Font, RL
    [J]. ARCHIVES OF OPHTHALMOLOGY, 2004, 122 (07) : 1060 - 1063
  • [4] CUTANEOUS AND CARDIAC VALVULAR PIGMENTATION WITH MINOCYCLINE
    BUTLER, JM
    MARKS, R
    SUTHERLAND, R
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1985, 10 (05) : 432 - 437
  • [5] CHAN CC, 1982, ARCH OPHTHALMOL-CHIC, V100, P1459
  • [6] New antiepileptic medication linked to blue discoloration of the skin and eyes
    Clark, Sarah
    Antell, Alexandra
    Kaufman, Kimberly
    [J]. THERAPEUTIC ADVANCES IN DRUG SAFETY, 2015, 6 (01) : 15 - 19
  • [7] CONJUNCTIVAL MELANIN DEPOSITIONS - A SIDE-EFFECT OF TOPICAL EPINEPHRINE THERAPY
    CORWIN, ME
    SPENCER, WH
    [J]. ARCHIVES OF OPHTHALMOLOGY, 1963, 69 (03) : 317 - &
  • [8] DELONG SL, 1965, ARCH OPHTHALMOL-CHIC, V73, P611
  • [9] SKIN PIGMENTATION DUE TO MINOCYCLINE TREATMENT OF FACIAL DERMATOSES
    DWYER, CM
    CUDDIHY, AM
    KERR, REI
    CHAPMAN, RS
    ALLAM, BF
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 1993, 129 (02) : 158 - 162
  • [10] Minocycline-induced pigmentation - Incidence, prevention and management
    Eisen, D
    Hakim, MD
    [J]. DRUG SAFETY, 1998, 18 (06) : 431 - 440